Vivos therapeutics to reschedule second quarter 2023 financial results conference call

Littleton, colo., aug. 14, 2023 (globe newswire) -- vivos therapeutics, inc. (“vivos” or the “company”) (nasdaq: vvos), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing related sleep conditions arising from certain dentofacial abnormalities, today announced it will reschedule its conference call to review its financial results for the second quarter ended june 30, 2023, previously scheduled for today at 5:00 p.m. (eastern time). further details for the second quarter financial results conference call will be provided in a subsequent announcement.
VVOS Ratings Summary
VVOS Quant Ranking